2va7

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 4: Line 4:
|PDB= 2va7 |SIZE=350|CAPTION= <scene name='initialview01'>2va7</scene>, resolution 2.20&Aring;
|PDB= 2va7 |SIZE=350|CAPTION= <scene name='initialview01'>2va7</scene>, resolution 2.20&Aring;
|SITE= <scene name='pdbsite=AC1:Iod+Binding+Site+For+Chain+A'>AC1</scene>, <scene name='pdbsite=AC2:Iod+Binding+Site+For+Chain+A'>AC2</scene>, <scene name='pdbsite=AC3:Iod+Binding+Site+For+Chain+A'>AC3</scene> and <scene name='pdbsite=AC4:C27+Binding+Site+For+Chain+A'>AC4</scene>
|SITE= <scene name='pdbsite=AC1:Iod+Binding+Site+For+Chain+A'>AC1</scene>, <scene name='pdbsite=AC2:Iod+Binding+Site+For+Chain+A'>AC2</scene>, <scene name='pdbsite=AC3:Iod+Binding+Site+For+Chain+A'>AC3</scene> and <scene name='pdbsite=AC4:C27+Binding+Site+For+Chain+A'>AC4</scene>
-
|LIGAND= <scene name='pdbligand=IOD:IODIDE+ION'>IOD</scene> and <scene name='pdbligand=C27:(6R)-2-amino-6-[2-(3&#39;-methoxybiphenyl-3-yl)ethyl]-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one'>C27</scene>
+
|LIGAND= <scene name='pdbligand=C27:(6R)-2-AMINO-6-[2-(3&#39;-METHOXYBIPHENYL-3-YL)ETHYL]-3,6-DIMETHYL-5,6-DIHYDROPYRIMIDIN-4(3H)-ONE'>C27</scene>, <scene name='pdbligand=IOD:IODIDE+ION'>IOD</scene>
-
|ACTIVITY= [http://en.wikipedia.org/wiki/Memapsin_2 Memapsin 2], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.23.46 3.4.23.46]
+
|ACTIVITY= <span class='plainlinks'>[http://en.wikipedia.org/wiki/Memapsin_2 Memapsin 2], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.23.46 3.4.23.46] </span>
|GENE=
|GENE=
 +
|DOMAIN=
 +
|RELATEDENTRY=[[1m4h|1M4H]], [[1sgz|1SGZ]], [[1w50|1W50]], [[1w51|1W51]], [[1xs7|1XS7]], [[1ym4|1YM4]], [[1fkn|1FKN]], [[1py1|1PY1]], [[1tqf|1TQF]], [[1ujj|1UJJ]], [[1ujk|1UJK]], [[1xn2|1XN2]], [[1xn3|1XN3]], [[1ym2|1YM2]], [[2b8l|2B8L]], [[2b8v|2B8V]], [[2va5|2VA5]], [[2va6|2VA6]]
 +
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2va7 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2va7 OCA], [http://www.ebi.ac.uk/pdbsum/2va7 PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=2va7 RCSB]</span>
}}
}}
Line 45: Line 48:
[[Category: Sylvester, M.]]
[[Category: Sylvester, M.]]
[[Category: Tian, G.]]
[[Category: Tian, G.]]
-
[[Category: C27]]
 
-
[[Category: IOD]]
 
[[Category: alternative splicing]]
[[Category: alternative splicing]]
[[Category: alzheimer's disease]]
[[Category: alzheimer's disease]]
Line 61: Line 62:
[[Category: zymogen]]
[[Category: zymogen]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Mar 23 15:53:23 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Mar 31 05:10:12 2008''

Revision as of 02:10, 31 March 2008


PDB ID 2va7

Drag the structure with the mouse to rotate
, resolution 2.20Å
Sites: , , and
Ligands: ,
Activity: Memapsin 2, with EC number 3.4.23.46
Related: 1M4H, 1SGZ, 1W50, 1W51, 1XS7, 1YM4, 1FKN, 1PY1, 1TQF, 1UJJ, 1UJK, 1XN2, 1XN3, 1YM2, 2B8L, 2B8V, 2VA5, 2VA6


Resources: FirstGlance, OCA, PDBsum, RCSB
Coordinates: save as pdb, mmCIF, xml



X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 27


Overview

Fragment-based lead generation has led to the discovery of a novel series of cyclic amidine-based inhibitors of beta-secretase (BACE-1). Initial fragment hits with an isocytosine core having millimolar potency were identified via NMR affinity screening. Structure-guided evolution of these fragments using X-ray crystallography together with potency determination using surface plasmon resonance and functional enzyme inhibition assays afforded micromolar inhibitors. Similarity searching around the isocytosine core led to the identification of a related series of inhibitors, the dihydroisocytosines. By leveraging the knowledge of the ligand-BACE-1 recognition features generated from the isocytosines, the dihydroisocytosines were efficiently optimized to submicromolar potency. Compound 29, with an IC50 of 80 nM, a ligand efficiency of 0.37, and cellular activity of 470 nM, emerged as the lead structure for future optimization.

About this Structure

2VA7 is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Application of fragment-based lead generation to the discovery of novel, cyclic amidine beta-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency., Edwards PD, Albert JS, Sylvester M, Aharony D, Andisik D, Callaghan O, Campbell JB, Carr RA, Chessari G, Congreve M, Frederickson M, Folmer RH, Geschwindner S, Koether G, Kolmodin K, Krumrine J, Mauger RC, Murray CW, Olsson LL, Patel S, Spear N, Tian G, J Med Chem. 2007 Nov 29;50(24):5912-25. Epub 2007 Nov 7. PMID:17985862

Page seeded by OCA on Mon Mar 31 05:10:12 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools